Going further
for patients
ANNUAL REPORT 2015
Download
PDF 4.2MB
HIGHLIGHTS
2015
1 APRIL 2015
Signature of a new Research Alliance agreement with
Harvard University
Download
PDF 57KB
1 APRIL 2015
Inauguration of Ipsen R&D center in Cambridge
Download
PDF 72KB
8 APRIL 2015
Signature of a joint research program
with Hannover
Medical School (Germany)
Download
PDF 239KB
19 MAY 2015
Acquisition of OctreoPharm
Sciences
Download
PDF 80KB
16 JULY 2015
Approval of Dysport
®
as a treatment for
adult upper-limb spasticity in the US
Download
PDF 102KB
3 AUGUST 2015
Positive results of telotristat etiprate
Download
PDF 297KB
6 JANUARY 2016
Expansion of Ipsen and Galderma neurotoxin partnership
Download
PDF 73KB
8 JANUARY 2016
Signature of a partnership with Belgium’s Aepodia
Link
17 FEBRUARY 2016
Signature of a licensing deal with 3B Pharmaceuticals
Download
PDF 300KB
1 MARCH 2016
Signature of an exclusive licensing agreement
with Exelixis
Download
PDF 158KB
8 MARCH 2016
Signature of a research partnership with PeptiMimesis
Download
PDF 1MB
Interview
with
Marc de Garidel
More
results
Voices of
experts
Jean-Pierre Bizzari
Interview
Gérard de Pouvourville
Interview
Robert Chu
Interview
Ron Evans
Interview
More
innovation
Ipsen
worldwide